PharmaBoardroom

The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you…

The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in…

Javier Anitua, Managing Director of Mylan Spain, discusses the preservation of Spain’s pharmacy model, preventive solutions for pharmacists, and the…

Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses…

“Although Pfizer is today one of the major contributors to Investigator-Initiated Research in Portugal in very important areas like inflammation,…

José Aranda da Silva, General Manager of Formifarma Portugal, stresses the importance of market access, demonstrating added value for companies…

Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote…

With budget cuts in response to the financial crisis barely touching the science sector, could it be that innovative pharmaceutical companies could…

TaiGen is on the brink of releasing Taiwan’s first innovative drug. In this interview, the Chairman and CEO of the company discusses the development…

The President & CEO of Vita Genomics talks about the advantages that genomic testing offer both to sick and healthy patients, as well as the…

The chairman and CEO of Medigen shares his insights on a significant past three years for the company, which included both an IPO and major…

You are the CEO of GCP CMIC ClinPlus in addition to R&G PharmaStudies, and before that you headed a number of companies as well. Could you…